BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Prognosis
10 results:

  • 1. Protein Kinase C Alpha (PKCα) overexpression leads to a better response to retinoid acid therapy through Retinoic Acid Receptor Beta (rarβ) activation in mammary cancer cells.
    Bessone MID; Berardi DE; Cirigliano SM; Delbart DI; Peters MG; Todaro LB; Urtreger AJ
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3241-3253. PubMed ID: 32865619
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Correlation between rar-β expression in lung squamous cell carcinoma tissues and prognosis.
    Hou PZ; Jian G; Ma ZQ; Xu Y
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4304-4310. PubMed ID: 29077166
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Promoter methylation of APC and rar-β genes as prognostic markers in non-small cell lung cancer (NSCLC).
    Feng H; Zhang Z; Qing X; Wang X; Liang C; Liu D
    Exp Mol Pathol; 2016 Feb; 100(1):109-13. PubMed ID: 26681652
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CHFR methylation strongly correlates with methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancer.
    Guo M; Alumkal J; Drachova T; Gao D; Marina SS; Jen J; Herman JG
    Discov Med; 2015 Mar; 19(104):151-8. PubMed ID: 25828518
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Retinoid expression (rarbeta and CRBP1) in non-small-cell lung carcinoma].
    Mauro LV; Dalurzo M; Smith D; Lastiri J; Vasallo B; Joffei EB; Pallotta MG; Puricelli L
    Medicina (B Aires); 2008; 68(3):205-12. PubMed ID: 18689151
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis.
    Brabender J; Metzger R; Salonga D; Danenberg KD; Danenberg PV; Hölscher AH; Schneider PM
    Carcinogenesis; 2005 Mar; 26(3):525-30. PubMed ID: 15618235
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Retinoic acid receptor-beta expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium.
    Chang YS; Chung JH; Shin DH; Chung KY; Kim YS; Chang J; Kim SK; Kim SK
    Yonsei Med J; 2004 Jun; 45(3):435-42. PubMed ID: 15227730
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
    Khuri FR; Wu H; Lee JJ; Kemp BL; Lotan R; Lippman SM; Feng L; Hong WK; Xu XC
    Clin Cancer Res; 2001 Apr; 7(4):861-7. PubMed ID: 11309334
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions.
    Martinet N; Alla F; Farré G; Labib T; Drouot H; Vidili R; Picard E; Gaube MP; Le Faou D; Siat J; Borelly J; Vermylen P; Bazarbachi T; Vignaud JM; Martinet Y
    Cancer Res; 2000 Jun; 60(11):2869-75. PubMed ID: 10850430
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.